“…The ability of Ivermectin to produce forward mutation at the thymidine kinase locus ( Tk +/-to Tk -/-) of mouse lymphoma Fischer L5178Y cells was studied, and negative results have also been reported for this end-point [Merck and Co., 1980a]. Effects of Ivermectin on unscheduled DNA synthesis were studied in IMR-90 20-60 g/ml 5-20 g/ml Negative Negative Merck and Co., 1980a In vitro unscheduled DNA synthesis IMR-90 human fibroblasts IMR-90 human fibroblasts + S9 300-1,000 g/ml 10-100 g/ml Negative Negative Merck and Co., 1980b In vitro comet assay CHO-K1 cells 5-50 g/ml Positive Molinari et al, 2009 In vitro sister chromatid exchanges Peripheral human lymphocytes ≥0.30 g/ml Positive Aleksić and Barjaktarović, 1993 In vitro sister chromatid exchanges Peripheral human lymphocytes Not specified Negative Aleksić et al, 1996 In vitro sister chromatid exchanges CHO-K1 cells 1-250 g/ml Negative Molinari et al, 2009 In vitro apoptosis induction Rat thymocytes 1 g/ml Negative Korystov et al, 1999 In vitro mitotic index CHO-K1 cells 1-250 g/ml Positive Molinari et al, 2009 In vitro cell-cycle progression CHO-K1 cells 1-250 g/ml Positive Molinari et al, 2009 In vitro neutral red assay CHO-K1 cells 0.25-250 g/ml Positive Molinari et al, 2009 In normal human embryonic lung fibroblasts in the presence and absence of rat liver microsomal activation systems. Regardless of the concentration employed, the drug did not produce any significant increase in background thymidine incorporation [Merck and Co., 1980b].…”